CN Stock MarketDetailed Quotes
688613 Allgens Medical Technology
- 12.29
- +0.29+2.42%
Market Closed Jul 5 15:00 CST
1.67BMarket Cap39.02P/E (TTM)
12.41High11.76Low10.75KlotVolume11.97Open12.00Pre Close13.03MTurnover0.79%Turnover Ratio30.73P/E (Static)135.55MShares25.0552wk High1.17P/B1.67BFloat Cap11.6152wk Low14.40Limit Up135.55MShs Float137.47Historical High9.60Limit Down5.42%Amplitude11.61Historical Low0.06Dividend TTM12.12Avg Price4.74KlotAsk0.49%Div YieldTTM100Lot Size5.69KlotBid
Allgens Medical Technology Key Stats
All
YOY
| (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | -22.78%40.22M | -11.95%210.51M | -0.07%174.15M | 17.43%114.54M | -10.92%52.08M | 0.23%239.09M | 7.77%174.28M | 6.50%97.54M | 46.97%58.46M | 29.47%238.55M |
| Refunds of taxes and levies | ---- | -54.74%2.33M | -48.24%2.33M | -49.04%2.29M | 139,045,858.79%2.29M | -65.77%5.15M | -46.91%4.5M | 329.33%4.5M | -100.00%1.65 | 728.51%15.04M |
| Cash received relating to other operating activities | -93.96%127.95K | 2.91%13.71M | 22.58%8.87M | -17.96%5.08M | -16.44%2.12M | -41.68%13.32M | -87.52%7.23M | -88.62%6.19M | -94.80%2.54M | -19.15%22.84M |
| Cash inflows from operating activities | -28.58%40.35M | -12.04%226.54M | -0.36%185.35M | 12.64%121.91M | -7.38%56.5M | -6.83%257.56M | -18.47%186.02M | -26.39%108.23M | -31.93%61M | 28.98%276.43M |
| Goods services cash paid | -59.71%7.41M | 56.68%62.97M | 87.10%51.11M | 2.45%26.52M | 3.16%18.39M | 19.08%40.19M | 35.48%27.32M | 189.61%25.88M | 1,523.65%17.83M | -17.38%33.75M |
| Staff behalf paid | 41.19%20.02M | 12.23%53.85M | 4.41%38.03M | -0.89%26.27M | -9.30%14.18M | 9.01%47.99M | 12.39%36.43M | 21.90%26.51M | 18.10%15.63M | 34.22%44.02M |
| All taxes paid | -55.09%3.88M | 19.87%18.85M | 41.10%16.44M | 197.61%13.49M | 191.59%8.63M | -55.77%15.72M | -57.91%11.65M | -76.15%4.53M | -56.11%2.96M | 98.98%35.54M |
| Cash paid relating to other operating activities | 293.09%11.13M | -24.05%39.19M | -34.13%37.55M | -7.81%24.73M | -82.02%2.83M | 54.72%51.6M | 7.28%57.01M | -45.80%26.82M | -62.21%15.74M | -12.06%33.35M |
| Cash outflows from operating activities | -3.63%42.44M | 12.45%174.86M | 8.10%143.15M | 8.67%91.01M | -15.58%44.04M | 6.02%155.5M | -0.75%132.42M | -15.56%83.75M | -16.86%52.17M | 13.31%146.67M |
| Net cash flows from operating activities | -116.78%-2.09M | -49.36%51.68M | -21.26%42.2M | 26.22%30.9M | 41.03%12.46M | -21.35%102.05M | -43.43%53.6M | -48.84%24.48M | -67.13%8.83M | 52.89%129.76M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | --25.55M | 96.95%31.51M | 90.70%30.51M | 90.70%30.51M | ---- | -54.55%16M | --16M | --16M | ---- | --35.2M |
| Cash received from returns on investments | ---- | 537.32%190.73K | 523.74%186.67K | 523.74%186.67K | ---- | -94.38%29.93K | -91.50%29.93K | -91.50%29.93K | -77.87%29.93K | -96.26%532.64K |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --130 | 343,566.67%206.2K | ---- | --0 | ---- | --60 | --60 | --60 | --60 | ---- |
| Cash received relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -24.80%16M | ---- |
| Cash inflows from investing activities | --25.55M | 99.06%31.91M | 91.51%30.7M | 91.51%30.7M | ---- | -55.14%16.03M | -47.53%16.03M | -47.53%16.03M | -25.13%16.03M | -90.87%35.73M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -71.30%4.27M | -51.78%21.9M | 25.70%29.16M | 19.17%24.9M | 6.26%14.9M | -25.81%45.42M | -46.68%23.19M | -23.21%20.89M | -32.42%14.02M | 8.55%61.22M |
| Cash paid to acquire investments | -99.90%45.52K | -23.76%128.09M | -10.56%112.7M | 10.59%87.37M | --46.51M | -17.65%168M | --126M | --79M | ---- | --204M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 71.88%55M | ---- |
| Cash outflows from investing activities | -92.97%4.32M | -29.72%149.99M | -4.92%141.86M | 12.39%112.26M | -11.03%61.41M | -19.53%213.42M | -20.00%149.19M | -1.30%99.89M | 30.86%69.02M | -50.39%265.22M |
| Net cash flows from investing activities | 134.58%21.23M | 40.18%-118.08M | 16.53%-111.16M | 2.74%-81.57M | -15.89%-61.41M | 13.99%-197.39M | 14.61%-133.16M | -18.69%-83.86M | -69.12%-52.99M | -60.17%-229.49M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | ---- | ---- | ---- | ---- | ---- | ---- | -99.99%51.68K | -100.00%504 | ---- | --508.33M |
| Cash from borrowing | ---- | --25M | --25M | --25M | ---- | ---- | ---- | ---- | ---- | 478.37%47.6M |
| Cash inflows from financing activities | ---- | --25M | 48,272.27%25M | 4,960,217.46%25M | ---- | ---- | -99.99%51.68K | -100.00%504 | ---- | 6,654.92%555.93M |
| Borrowing repayment | -75.47%1.3M | 272.65%32.05M | 266.84%31.55M | 816.60%30.25M | 60.61%5.3M | -75.12%8.6M | -75.12%8.6M | -89.45%3.3M | -89.45%3.3M | 1,229.62%34.57M |
| Dividend interest payment | -23.75%681.19K | -57.47%17.06M | -58.01%16.38M | -19.23%1.62M | 212.35%893.36K | 3,139.03%40.12M | 1,699.32%39.01M | 214.45%2M | -11.85%286.01K | -11.39%1.24M |
| Cash payments relating to other financing activities | ---- | 14.65%8.11M | ---- | ---- | ---- | -76.36%7.07M | ---- | --0 | --0 | --29.91M |
| Cash outflows from financing activities | -68.01%1.98M | 2.55%57.22M | 0.67%47.93M | 500.89%31.87M | 72.71%6.19M | -15.10%55.79M | -28.38%47.61M | -84.26%5.3M | -88.65%3.59M | 1,543.74%65.72M |
| Net cash flows from financing activities | 68.01%-1.98M | 42.25%-32.22M | 51.79%-22.93M | -29.48%-6.87M | -72.71%-6.19M | -111.38%-55.79M | -109.72%-47.56M | -101.02%-5.3M | -122.40%-3.59M | 11,483.50%490.21M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | ---- | 100.03%87.61 | ---- | --0 | ---- | -10,681.87%-301.1K | 231.63%626.79 | 133.23%337.81 | -78.19%633.68 | 102.11%2.85K |
| Net increase in cash and cash equivalents | 131.12%17.16M | 34.88%-98.62M | 27.72%-91.88M | 11.05%-57.53M | -15.51%-55.14M | -138.78%-151.43M | -129.68%-127.12M | -112.95%-64.68M | -513.26%-47.74M | 819.05%390.49M |
| Add:Begin period cash and cash equivalents | -37.95%161.25M | -36.82%259.87M | -36.82%259.87M | -36.82%259.87M | -36.82%259.87M | 1,875.80%411.31M | 1,875.80%411.31M | 1,875.80%411.31M | 1,875.80%411.31M | -72.29%20.82M |
| End period cash equivalent | -12.85%178.41M | -37.95%161.25M | -40.89%167.99M | -41.63%202.34M | -43.69%204.73M | -36.82%259.87M | -36.72%284.19M | -33.37%346.63M | 1,023.19%363.57M | 1,875.80%411.31M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | -- |
| Auditor | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
CN
Overall
Symbol
Latest Price
%Chg